Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.23.1
Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2021 1,183,599      
Balance at Sep. 30, 2021 $ 1,184 $ 48,770,061 $ (49,796,919) $ (1,025,674)
Net loss $ 0 0 (2,340,465) (2,340,465)
Vesting of restricted stock (in shares) 1,000      
Vesting of restricted stock $ 1 (1) 0 0
Stock-based compensation expense $ 0 306,715 0 306,715
Balance (in shares) at Mar. 31, 2022 1,184,599      
Balance at Mar. 31, 2022 $ 1,185 49,076,775 (52,137,384) (3,059,424)
Balance (in shares) at Dec. 31, 2021 1,183,974      
Balance at Dec. 31, 2021 $ 1,184 48,922,204 (51,347,066) (2,423,678)
Net loss     (790,318) (790,318)
Vesting of restricted stock (in shares) 625      
Vesting of restricted stock $ 1 (1) 0 0
Stock-based compensation expense   154,572   154,572
Balance (in shares) at Mar. 31, 2022 1,184,599      
Balance at Mar. 31, 2022 $ 1,185 49,076,775 (52,137,384) (3,059,424)
Balance (in shares) at Sep. 30, 2022 1,252,665      
Balance at Sep. 30, 2022 $ 1,252 50,878,718 (55,072,773) (4,192,803)
Net loss $ 0 0 (2,702,533) (2,702,533)
Vesting of restricted stock (in shares) 250      
Vesting of restricted stock $ 0 0 0 0
Stock-based compensation expense $ 0 172,550 0 172,550
Issuance of common stock and warrants, net of financing costs (in shares) 9,598      
Issuance of common stock and warrants, net of financing costs $ 10 287,410 0 287,420
Exchange of warrants into common stock (in shares) 12,019      
Exchange of warrants into common stock $ 13 49,265   49,278
Balance (in shares) at Mar. 31, 2023 1,274,532      
Balance at Mar. 31, 2023 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Balance (in shares) at Dec. 31, 2022 1,252,665      
Balance at Dec. 31, 2022 $ 1,252 50,982,744 (56,872,829) (5,888,833)
Net loss $ 0 0 (902,477) (902,477)
Vesting of restricted stock (in shares) 250      
Vesting of restricted stock $ 0 0 0 0
Stock-based compensation expense   68,524 0 68,524
Issuance of common stock and warrants, net of financing costs (in shares) 9,598      
Issuance of common stock and warrants, net of financing costs $ 10 287,410 0 287,420
Exchange of warrants into common stock (in shares) 12,019      
Exchange of warrants into common stock $ 13 49,265 0 49,278
Balance (in shares) at Mar. 31, 2023 1,274,532      
Balance at Mar. 31, 2023 $ 1,275 $ 51,387,943 $ (57,775,306) $ (6,386,088)